Triple-Negative Breast Cancer
Triple-Negative Breast Cancer is a scholarly work, published in 2012 in ''International Journal of Breast Cancer''. The main subjects of the publication include breast cancer, bioinformatics, tumor protein p53, double negative, oncology, cancer, triple-negative breast cancer, medicine, and disease. Ever since the seminal work that was published by Perou et al., triple-negative breast cancer (TNBC) has become a common lexicon among clinicians who care for patients with breast cancer.Beside portending a poor outcome, TNBC is unique in that, unlike the hormone-positive and Her-2positive cancer cells, it lacks target specific therapy.This is likely the result of the authors' lack of having a clear understanding of its biology.In this special issue, authors were highly selective of only papers that authors thought might further advance the authors' understanding of the disease.Thus, the papers vary widely from the role of race/ethnicity to the metabolic/molecular influence that can potentially impact the biology of the disease.We hope that this special issue will serve as a focal point to continue the authors' ongoing discussion about this challenging entity.